21 June 2024
21 June 2024
The Brigham and Women’s Hospital will be a study site for Micobot’s Liberty Endovascular Robotic Surgical System’s pivotal clinical trial.
The funding was co-led by Chinese venture funds INCE Capital and Guolian Capital.
The collaboration enhances Medtronic's offerings for vertebral compression fracture (VCF) treatments.
The US patent has been awarded for the company’s advanced Gen-2 and Gen-3 non-invasive brain stimulation device.
The multicentre trial will see 30 adults living with degenerative disc disease treated with the company’s NB1 device designed to regenerate bone faster.
Roche’s Ventana B-cell lymphoma diagnostic assay can detect and differentiate B-cell lymphomas and plasma cell neoplasms from a normal immune response.
The development paves the way for Femasys to commence commercialisation efforts for the products within the European market.
The new device demonstrated positive results for cancer immunotherapy by training immune cells to target and destroy tumours.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
